Page 128 - SRPSKO DRUŠTVO ISTRAŽIVAČA RAKA
P. 128

Serbian Association for Cancer Research                                                       SDIRSACR

        Conclusions: Variations in ATG10 and ATG5 genes are associated with blood/inflammatory cells counts/ratios at BL and
        clinical course of advanced melanoma.

        Acknowledgments and funding: Science fund of Republic of Serbia, ReDiMEL project No 6795





                                                                                                             P33

         Identification and characterization of microRNAs involved in the progression from normal oral mucosa to
                                                                                                      oral cancer

                                                                    Katarina Zeljic1, Dunja Pavlovic2, Goran Stojkovic 3, 4

                                                                1University of Belgrade – Faculty of Biology, Belgrade, Serbia
                                 2University of Belgrade – Institute of Molecular Genetics and Genetic Engineering, Belgrade, Serbia
                                                               3University of Belgrade – Faculty of Medicine, Belgrade, Serbia
                                4University Clinical Center, Clinic for Otorhinolaryngology and Maxillofacial Surgery, Belgrade, Serbia

        Keywords: oral mucosa, oral leukoplakia, oral cancer, miRNA

        Background: The development of oral cancer is a complex, multistep process involving the transformation of normal
        oral mucosa into premalignant lesions, such as oral leukoplakia with dysplasia, and eventually into oral cancer. A key
        feature  of  this  transformation  is  the  deregulation  of  small  non-coding  RNA  molecules,  microRNAs  (miRNAs).  The
        identification of miRNAs that are consistently deregulated at different stages of oral carcinogenesis is crucial to gaining
        deeper insights into the molecular changes involved. Our aim was to identify and characterize commonly deregulated
        miRNAs in normal oral mucosa, oral leukoplakia, and oral cancer using publicly available databases.
        Material and Methods: The National Center for Biotechnology Information Gene Expression Omnibus (NCBI GEO) was
        utilized to identify databases containing miRNA expression data from normal oral mucosa, oral leukoplakia, and oral
        cancer. Data from the GSE246050 dataset were analyzed using GEO2R software. Raw fastq files were retrieved from
        Sequence Read Archive (SRP468035). HISAT2 and StringTie were used for identification and quantification of miRNA
        transcripts. A list of miRNAs commonly deregulated was further characterised by miRNet v2.0 software.
        Results:  In  total  112  genes  were  identified  as  commonly  differentially  deregulated  across  normal  oral  mucosa,
        leukoplakia  with  dysplasia  and  oral  cancer.  Among  them  were  6  microRNA  genes:  MIR429,  MIR6726,  MIR135B,
        MIR204, MIR139 and MIR211. Analysis of expression profiles of mature transcripts of these miRNA genes, revealed
        significant changes in expression of hsa-miR-429, hsa-miR-135b-5p, hsa-miR-135b-3p, hsa-miR-204-5p, hsa-miR-139-
        5p, hsa-miR-139-3p and hsa-miR-211-5p. We observed progressive upregulation of hsa-miR-429 and hsa-miR-135b-
        5p/3p, while downregulation of hsa-miR-204-5p, hsa-miR-139-5p/3p and hsa-miR-211-5p in progression from normal
        oral mucosa to oral cancer. To investigate the function of all genes regulated by miRNAs, a hypergeometric test and the
        KEGG database were used. Pathways in cancer were significantly enriched with the largest number of genes.
        Conclusions: Progression from normal oral mucosa to oral cancer might be characterized by up-regulation of hsa-
        miR-429,  hsa-miR-135b-5p/3p  and  down-regulation  of  hsa-miR-204-5p,  hsa-miR-139-5p/3p  and  hsa-miR-211-5p.
        These results are good starting point for further validation of miRNA candidates in oral carcinogenesis in a larger group
        of clinical samples.

        Acknowledgments and funding: This study was supported by the Ministry of Science, Technological Development and
        Innovation of the Republic of Serbia [grant agreement: 451-03-137/2025-03/200178].



















                                                                                                                  113
   123   124   125   126   127   128   129   130   131   132   133